Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

18.09 0.28 −1.52%
Market cap
$382.4M
P/E
0.0×
Fwd P/E
−8.4×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Dec '25 Dec '24
P/E ratio
0.00 0.00
Altman Z-Score
2.53 —
P/S ratio
2.62 0.05
Altman Z″-Score (non-manufacturers)
7.68 (1.53)
P/FCF ratio
0.00 0.00
P/Operating CF
(14.12) (0.36)
Beneish M-Score
(2.42) —
P/B ratio
0.88 0.00
EV/Sales
0.31 (0.63)
EV/EBITDA
0.00 1.45
EV/FCF
(0.41) 0.98
Current Ratio
11.07 4.59
Net Debt/EBITDA
4.79 0.03
Debt/Equity
0.11 0.74
ROE
(93.80%) 0.00%
ROA
(37.90%) 0.00%
ROIC
(52.42%) (47.22%)
Return on Tangible Assets
(25.95%) (44.67%)
Average Days of Receivables
63.78 59.12
Earnings Yield
(1,529.23%) (2,386.39%)
Free Cash Flow Yield
(29.04%) (1,356.23%)
Free Cash Flow per Share
(4.15) (281.52)
Book value per Share
16.23 306.67
Free Cash Flow
(36.02) (18.16)
EV/EBIT
0.00 1.28
Other line items

Show all line items

Columns are period end dates